Sheary B. Topical Steroid Withdrawal: A Case Series of 10 Children. Acta Dermato-Venereologica. e-publication 2019. doi: 10.2340/00015555-3144  Accessed 3/24/19 at Belinda_Sheary_TSW_in_10_kids_case_series

Juhász MLW, Curley RA, Rasmussen A, Malakouti M, Silverberg N, Jacob E. Systematic review of the topical steroid addiction and topical steroid withdrawal phenomenon in children diagnosed with atopic dermatitis and treated with topical corticosteroids. Journal of the Dermatology Nurses’ Association: September/October 2017; 9(5):233-240. doi: 10.1097/JDN.0000000000000331 Juhasz_Curley_Systematic_Review_of_the_Topical_Steroid_Addiction.2-4.pdf

Berger T., Francis-Lyon P., Parker J., Friedman P., Sengar P., Owens J. Analysis of patient-reported symptoms with respect to TCS usage: a self-identified cohort of patients with RSS/TSA/TSW. Journal of the American Academy of Dermatology, 76(6) Supplement 1, AB44. doi:10/1016/j.jaad/2017/04/189

Sheary B. Topical corticosteroid addiction and withdrawal–An overview for GPs. Australian Family Physician. 2016; 45(6):386-388.–-an-overview-for-gps/ Belinda_Sheary_TSW_for_GP

Curley R. “Thinking Outside the Topical Steroid Box: Topical Steroid Withdrawal (TSW) in Children.” Poster presentation April 7, 2016 at RISE Expo 2016. Northeastern University; Boston, Massachusetts.

Fukaya, M, Sato K, Yamada T, et al. A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period. Clin Cosmet Investig Dermatol. 2016; 9:151-158.  doi: 10.2147/CCID.S109946

Novak E and Allen PJ. Prescribing medications in pediatrics: Concerns regarding FDA approval and pharmacokinetics. Pediatric Nursing. 2007; 33(1):64-70.

Rapaport MJ and Rapaport VH. Serum nitric oxide levels in “red” patients: Separating corticosteroid addicted patients from those with chronic eczema. Arch Dermatol. 2001;140(8):1013-1014.

Fukaya M. Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis with Topical Steroid Addiction. Dermatology and Therapy. pp. 1-8. 2/2/2016. Accessed 2/4/16 at    doi:10.1007/s13555-016-0096-7

Eichenfield LF, Boguniewicz M, Simpson, EL, Russell JJ, Block JK, Feldman SR, et al. Translating atopic dermatitis Management Guidelines into practice for primary care providers. Pediatrics. 2015;136(3):554-565.  doi: 10.1542/peds.2014-3678

Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson, EL, et al. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014;70:338-51.

Eichenfield L, Tom W, Berger T, et al. Guidelines of care for the management of atopic dermatitis Section 2 Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014; 71(1):121-124.

DOI: Eczema Association. “Risk of topical corticosteroids” under Eczema treatment/topical steroids. Online. Copyright 2015. Accessed on 1/31/15.

National Eczema Association. “Eczema prevention checklist” under Eczema treatment. Online. Copyright 2015. Accessed on 1/29/15.

Fukaya M, Sato K, Sato M, et al. Topical steroid addiction in atopic dermatitis. Drug, Healthcare Patient Safety. 2014:6 131. DOI:

Hajar T, Leshem YA, Hanifin JM, Nedorost, ST, Lio PA, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2. Epub 2015 Jan 13. DOI:

Rapaport MJ, Rapaport V. The Red skin syndromes: corticosteroid addiction and withdrawal. Expert Rev. Dermatolo. 2006;1(4):547-561.

Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006;54:1-15.

Kligman AM, Frosch PJ. Steroid addiction. International Journal of Dermatology Jan. 1979; 18(1):23-31.

Rapaport MJ, Rapaport V. Eyelid dermatitis to red face syndrome to cure: clinical experience in 100 cases. J Am Acad Dermatol. 1999 Sept;41(3 Pt 1):435-42.

Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003 May-Jun; 21(3):201-14.

Rapaport MJ, Rapaport V. The Red skin syndromes: corticosteroid addiction and withdrawal. Expert Rev. Dermatolo. 2006;1(4):547-561.

Michael J Cork, Simon G Danby, Yiannis Vasilopoulos, Jonathan Hadgraft, Majella E Lane, Manar Moustafa, Richard H Guy, Alice L MacGowan, Rachid Tazi-Ahnini and Simon J Ward. Epidermal Barrier Dysfunction in Atopic Dermatitis. Journal of Investigative Dermatology (2009) 129, 1892–1908.  doi:10.1038/jid.2009.133; published online 4 June 2009.

Weaver J. Post-marketing Safety Review–PID D0141 Drugs: Topical Corticosteroids (FDA Memorandum). July 9, 2001. Weaver 2001 memorandum FDA_TopicalSteroids

Ghosh A, Sengupta S, Condo A, Jana A. Topical corticosteroid addiction and phobia. Indian J Dermal. 2014 Sept-Oct; 59(5):465-468.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s